VIEMED HEALTHCARE, INC. 8-K

What Happened
Viemed Healthcare, Inc. (VMD) filed an 8-K reporting results of its Annual General and Special Meeting of Shareholders held June 4, 2026. Shareholders approved a Second Amendment to the Company’s 2024 Long Term Incentive Plan (effective June 4, 2026) that increases the total number of common shares reserved for issuance under the 2024 LTIP and prior equity plans to 7,696,717 shares (including a 1,000,000-share limit for incentive stock options). All seven director nominees were re-elected, and Ernst & Young LLP was approved as independent auditors for fiscal 2026. Shareholders also approved the company’s advisory “say-on-pay” vote.

Key Details

• LTIP amendment: total reserved shares increased to 7,696,717 common shares; up to 1,000,000 may be issued as incentive stock options. (Second Amendment filed as Exhibit 10.1)
• Director elections: seven nominees re-elected; example vote totals — Casey Hoyt: 21,367,697 (95.46%); Sabrina Heltz: 17,853,293 (79.76%) with 4,530,263 withheld. Broker non-votes for director election: 5,139,303.
• Auditor appointment: Ernst & Young LLP approved as independent auditors for year ending Dec 31, 2026 (26,860,081 votes for; 97.59%).
• Other votes: LTIP amendment ratified (19,888,046 for; 88.85%; 2,267,640 against; 227,867 abstain); advisory say-on-pay passed (20,863,084 for; 93.21%).

Why It Matters
Approval of the LTIP amendment increases the pool of shares available for equity compensation, which can affect dilution and how the company incentivizes employees and executives. Re-election of the full board and strong support for the say-on-pay vote indicate continued shareholder backing of management and compensation practices, though one director (Sabrina Heltz) received notably lower support. The auditor appointment confirms external audit continuity for fiscal 2026. Investors should note the increased share reserve and vote outcomes as they assess potential dilution and governance signals.